1. THU0306 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of The BCL-2 Inhibitor Venetoclax (ABT-199) in A Phase 1 Single and Multiple Ascending Dose Study in Female Patients with Systemic Lupus Erythematosus. (15th July 2016) Authors: Lu, P.; Fleischmann, R.; Curtis, C.; Ignatenko, S.; Desai, M.; Wong, S.L.; Grebe, K.M.; Zeng, J.; Medema, J.; Stolzenbach, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗